1% Lignocaine Flashcards
1% Lignocaine Mechanism of action
- Lignocaine is a local anaesthetic.
- Lignocaine blocks the initiation and transmission of nerve impulses by blocking the movement of sodium ions across the nerve cell membrane.
1% Lignocaine Indications
Subcutaneous injection for prophylaxis of pain associated with IV cannulation.
Subcutaneous injection for digital ring blocks for analgesia.
Intraosseous injection for bone pain associated with fluid infusion via an intraosseous needle.
1% Lignocaine Contraindications
Known severe allergy.
Local infection in the area of injection.
1% Lignocaine Cautions
Taking an anticoagulant (ring blocks).
1% Lignocaine Use in pregnancy
Safe, may be administered if indicated
1% Lignocaine Subcutaneous Dose
a) The maximum subcutaneous dose for an adult is 200 mg (20 ml of 1% lignocaine).
b) See the paediatric drug dose tables for the maximum dose for a child.
c) The subcutaneous dose may be repeated once after 30 minutes.
1% Lignocaine Intraosseous Dose
a) 50 mg (5 ml of 1% lignocaine) for an adult.
b) See the paediatric drug dose tables for a child.
c) The intraosseous dose may be repeated once after 15 minutes.
1% Lignocaine Subcut for IV insertion Administration
Administer into the subcutaneous tissue at the site of cannulation. Raise a bleb and wait approximately one minute before insertion.
1% Lignocaine Digital ring blocks Administration
Administer approximately 1-2 ml of 1% lignocaine into the
tissue on either side of the web space of the digit.
1% Lignocaine IO Administration
Administer slowly over 1-2 minutes and wait one further minute before infusing fluid. This is intended to limit the amount of lignocaine flushed into the circulation.
1% Lignocaine Common adverse effects
Stinging at site of injection
1% Lignocaine Duration of action
30-60 minutes
1% Lignocaine Usual Preparation
50mg in 5ml
1% Lignocaine Usual onset of effect
- 1-2 minutes for IV cannulation.
* 5-10 minutes for digital ring blocks.
1% Lignocaine Pharmacokinetics
- Lignocaine is metabolised in the liver.
* There are no significant effects from liver impairment on acute administration.